Sixth-Generation Troponin T Test Shows High Accuracy for Heart Attack Diagnosis
Study of more than 13,000 individuals demonstrates improved precision for emergency department triage and patient outcomes.
Study of more than 13,000 individuals demonstrates improved precision for emergency department triage and patient outcomes.
Researchers identified 27 protein biomarkers in blood serum that can predict cardiomyopathy risk in pediatric cancer survivors.
A study found that elevated blood levels of LDL cholesterol, Lp(a), and CRP significantly increase long-term cardiovascular risk.
Siemens Healthineers introduced the NT-proBNPII assay to its Atellica Solution, enhancing rapid diagnostic capabilities for heart failure.
Read MoreRoche announced that its Tina-quant lipoprotein Lp(a) RxDx assay received Breakthrough Device Designation from the FDA.
Read MoreResearchers developed a genetic testing procedure that can identify patients at high risk for cardiovascular diseases.
Read MoreAnalytics for Life and CorVista Health announced U.S. FDA clearance of the CorVista System with Pulmonary Hypertension (PH) Add-On Module
Read MoreThe new high-sensitivity troponin assay is designed for use on the the PATHFAST Biomarker Analyzer from Polymedco.
Read MoreBodyport says its biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events.
Read MoreThe measurement of six blood biomarkers improved the ability of researchers to predict a future increase in arterial inflammation.Â
Read MoreCombining the results of a standard blood test and an online tool can help identify those who are at risk of having a heart attack.
Read MoreResearchers extracted data on 321 biomarkers and found 13 were significantly associated with cardiovascular risk in type 2 diabetes patients.
Read MoreThe biomarkers may help more quickly predict cardiomyopathy in high-risk, asymptomatic childhood cancer survivors.Â
Read MoreA two-step screening protocol can effectively identify which patients with Type 2 diabetes need medication to prevent heart failure.
Read MorePatients with a heart muscle injury caused by other heart conditions benefitted the most from the new troponin measurement method.
Read MoreBio-Rad Laboratories expanded the compatibility of its newest cardiac control, Cardiac Advance, to now include Beckman-Coulter instruments. Â
Read MoreNext-gen cardiometabolic biomarkers will aid earlier detection of risk factors for obesity, diabetes, and heart disease in children.
Read MoreMindray introduced new cardiac biomarkers aimed at diversifying its portfolio for cardiovascular disease diagnosis and management.
Read More